{"id":845505,"date":"2025-05-01T16:12:51","date_gmt":"2025-05-01T20:12:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/"},"modified":"2025-05-01T16:12:51","modified_gmt":"2025-05-01T20:12:51","slug":"zevra-therapeutics-to-participate-in-the-citizens-life-science-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/","title":{"rendered":"Zevra Therapeutics to Participate in the Citizens Life Science Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CELEBRATION, Fla., May  01, 2025  (GLOBE NEWSWIRE) &#8212; Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra\u2019s executive leadership team will participate in a fireside chat at the Citizens Life Science Conference in New York, NY, on Wednesday, May 7, 2025, at 11:30 a.m. ET.<\/p>\n<p align=\"justify\">Additionally, management will be available for one-on-one meetings with registered attendees at each conference. The live webcasts will be accessible via \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FAPiKV1PbbBplFlD9RUPolnikVdabD-NYU2nNNylRduwwjTQqCDM2a-e86wJ6mzWmtJdOxi3gZi0ChCqILd_7-mtjByhJznieMfeI44Lry2yRv0gUwgKvk7VA7t0EPkDpv6Wf5jDQPW1PoznOqEgL3Io65vNjSs_CtU_wZwj2oJ1iCL237Np_JrUO82w8j3TkbarVzDaoxH8coe8BKi8J5hpB6hvI6VIsfIwrcIC5ltgKoDORw-y6fHfGbzZ9P1dem24zHtEMdn9bZOrRhSE6_cYVdpJFL4FcuKIWm9B-ZxHRcQC6o8Runlwt4BIW__bv5ZovICyb7jG_CotmYQbxQ==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d on the Investor Relations section of Zevra\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Bn7Wazgz5Ghh-0xRBsK1Yb9WuuQw5SK18B_SE2ByarHA8nWJrPOV0S1YCPTmnKDx_cvCqKKgFPtD0jOMhy0279g9wCr0MJAXkKHZ8XjPGabTcFbRqAAwoleBo9THlxkEFUs_l9aOMI82LO3VwwZLzepUoCzQMk9JzXibJO15Hn6Wn2F17O4hvgNKq5IpgRtvIDs7pVR0hNiaukvx9kh4MxHFQkZeJ7ojMLC7QOgTzozrbFM8adqRutVGkJsaanDlAause1BBcwQvBTq_XKCqtXi8uDBRioxZg6W_u72Fow=\" rel=\"nofollow\" target=\"_blank\">investors.zevra.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Zevra Therapeutics, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Zevra Therapeutics, Inc. is a commercial-stage company combining science, data, and patient need to create transformational therapies for rare diseases with limited or no treatment options. Our mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, the Company is overcoming complex drug development challenges to make new therapies available to the rare disease community.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DiRl75LgQIJ640IClglVyCeTJEUUNo7qecoRNGKf5LkQq22HGwejRF2-H75DznryVXZVsIwuWuzfWy8IXuKzHA==\" rel=\"nofollow\" target=\"_blank\">www.zevra.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VFkBiFAwuKz-l8cP-SLfFADIWfRviOiFzD8E7xcxR_GoH0yrruv8jKoPYhCWN20KVTds88lxO1w7tbOZyuBTX-A97Y1j1E0O-xaUFJA-pWo2VcsOyUBaHnjOGXXp-wjPNDJQTpnNXsfNX2NYzz8TPe790E5KhUA5dEYvcqHt-noysPBuHLeFT9L7j5HH5QSolMwWRMhP-orm9JMygtd0E6q6_aDjt3LTPPcYI_2EhceLDvDw6Bv6FT-JA-bQ0a7l9ZWQIQikmXgIn8dVKnalnVnKc4eD7jJtrlGwYM3lYwg=\" rel=\"nofollow\" target=\"_blank\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GF0zhzoUgMDm83Swwumsv7RZwjWtX46MZ61lZUSkoCJjqGRc2qNxOyr5_SQSaWkn3d7IxFqCCL9ZqnFcaaJsotdV89qgVlsSPZCgTBuV_rP-vbMqMnN8p1EBnF9anRbAxoqQ1HFJCaetjlRyF-HfosVL2IFDvPPql_TEgcuQbR-CEZOo3DrypEywHqahzTZd1SLJ2l-jmcHkcG7YpSv7258tbCj8HHlqBHO6NUKnbT3zufNstzGkxq8vL9_wd8DjEEdOjNHewaTisNMDXJ2Uzg==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Caution Concerning Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding upcoming events or Zevra\u2019s participation at such events. Forward-looking statements are based on information currently available to Zevra and its current plans or expectations. They are subject to several known and unknown uncertainties, risks, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. These and other important factors are described in detail in the &#8220;Risk Factors&#8221; section of Zevra\u2019s Annual Report on Form 10-K for the year ended Dec. 31, 2024, and Zevra\u2019s other filings with the Securities and Exchange Commission. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. Although we believe the expectations reflected in such forward-looking statements are reasonable, we cannot assure that such expectations will prove correct. These forward-looking statements should not be relied upon as representing our views as of any date after the date of this press release.\u00a0<\/p>\n<p>\n        <strong>Zevra Contact<\/strong>\n      <\/p>\n<p>Nichol Ochsner\u00a0<br \/>+1 (732) 754-2545\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5xrYbkeOm4xmj4VqVOu3ujENmcvMwnjD7-KSdKn_l9d-1NeDLjEg99utsA_AI3eOvpNzpGX6_Ocrp-LdUq23NQtbp6xG4ELvM5Qvx9p3ZFs=\" rel=\"nofollow\" target=\"_blank\"><u>nochsner@zevra.com<\/u><\/a><strong>\u00a0<\/strong>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/N2MwOTgzNmItOTE5Ny00YmJhLWE3YjItMmJhNWM1NzU3MTkxLTEwMjkzMjgtMjAyNS0wNS0wMS1lbg==\/tiny\/Zevra-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) &#8212; Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra\u2019s executive leadership team will participate in a fireside chat at the Citizens Life Science Conference in New York, NY, on Wednesday, May 7, 2025, at 11:30 a.m. ET. Additionally, management will be available for one-on-one meetings with registered attendees at each conference. The live webcasts will be accessible via \u201cEvents &amp; Presentations\u201d on the Investor Relations section of Zevra\u2019s website at investors.zevra.com. About Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. is a commercial-stage company combining science, data, and patient need to create transformational therapies for rare diseases with limited or no treatment &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zevra Therapeutics to Participate in the Citizens Life Science Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-845505","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zevra Therapeutics to Participate in the Citizens Life Science Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zevra Therapeutics to Participate in the Citizens Life Science Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) &#8212; Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra\u2019s executive leadership team will participate in a fireside chat at the Citizens Life Science Conference in New York, NY, on Wednesday, May 7, 2025, at 11:30 a.m. ET. Additionally, management will be available for one-on-one meetings with registered attendees at each conference. The live webcasts will be accessible via \u201cEvents &amp; Presentations\u201d on the Investor Relations section of Zevra\u2019s website at investors.zevra.com. About Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. is a commercial-stage company combining science, data, and patient need to create transformational therapies for rare diseases with limited or no treatment &hellip; Continue reading &quot;Zevra Therapeutics to Participate in the Citizens Life Science Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-01T20:12:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zevra Therapeutics to Participate in the Citizens Life Science Conference\",\"datePublished\":\"2025-05-01T20:12:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/\"},\"wordCount\":418,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/\",\"name\":\"Zevra Therapeutics to Participate in the Citizens Life Science Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=\",\"datePublished\":\"2025-05-01T20:12:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zevra Therapeutics to Participate in the Citizens Life Science Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zevra Therapeutics to Participate in the Citizens Life Science Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/","og_locale":"en_US","og_type":"article","og_title":"Zevra Therapeutics to Participate in the Citizens Life Science Conference - Market Newsdesk","og_description":"CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) &#8212; Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra\u2019s executive leadership team will participate in a fireside chat at the Citizens Life Science Conference in New York, NY, on Wednesday, May 7, 2025, at 11:30 a.m. ET. Additionally, management will be available for one-on-one meetings with registered attendees at each conference. The live webcasts will be accessible via \u201cEvents &amp; Presentations\u201d on the Investor Relations section of Zevra\u2019s website at investors.zevra.com. About Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. is a commercial-stage company combining science, data, and patient need to create transformational therapies for rare diseases with limited or no treatment &hellip; Continue reading \"Zevra Therapeutics to Participate in the Citizens Life Science Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-01T20:12:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zevra Therapeutics to Participate in the Citizens Life Science Conference","datePublished":"2025-05-01T20:12:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/"},"wordCount":418,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/","name":"Zevra Therapeutics to Participate in the Citizens Life Science Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=","datePublished":"2025-05-01T20:12:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAxMCM2OTE2OTI4IzIwMTc3NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zevra-therapeutics-to-participate-in-the-citizens-life-science-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zevra Therapeutics to Participate in the Citizens Life Science Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/845505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=845505"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/845505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=845505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=845505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=845505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}